Literature DB >> 20857242

Giant cell arteritis: epidemiology, diagnosis, and management.

Miguel A Gonzalez-Gay1, Cristina Martinez-Dubois, Mario Agudo, Orlando Pompei, Ricardo Blanco, Javier Llorca.   

Abstract

Giant cell arteritis (GCA), also called temporal arteritis, is a vasculitis that affects large and middle-sized blood vessels--with predisposition to the involvement of cranial arteries derived from the carotid artery--in individuals older than 50 years of age. Familial aggregation of GCA has been observed. Incidence of GCA is higher in white individuals than those of other ethnicities, particularly those of Scandinavian background. A temporal artery biopsy is the gold standard test for the diagnosis of GCA. Several imaging modalities, in particular ultrasonography, are useful in the diagnosis of GCA. Corticosteroids are the cornerstone of treatment in GCA. Alternative, steroid-sparing drugs, particularly methotrexate, should be considered in GCA patients with severe corticosteroid-related side effects and/or in those who require prolonged corticosteroid therapy due to relapses of the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20857242     DOI: 10.1007/s11926-010-0135-9

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  50 in total

1.  Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study.

Authors:  G G Hunder; S G Sheps; G L Allen; J W Joyce
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

2.  Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis.

Authors:  T A Bley; M Reinhard; C Hauenstein; M Markl; K Warnatz; A Hetzel; M Uhl; P Vaith; M Langer
Journal:  Arthritis Rheum       Date:  2008-08

3.  Temporal artery biopsy for giant cell arteritis.

Authors:  Regina Taylor-Gjevre; Minh Vo; Dino Shukla; Lothar Resch
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

4.  The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations.

Authors:  V Petursdottir; H Johansson; E Nordborg; C Nordborg
Journal:  Rheumatology (Oxford)       Date:  1999-12       Impact factor: 7.580

5.  Neurologic disease in biopsy-proven giant cell (temporal) arteritis.

Authors:  R J Caselli; G G Hunder; J P Whisnant
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

6.  Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.

Authors:  Miguel A Gonzalez-Gay; Angela Piñeiro; Adriana Gomez-Gigirey; Carlos Garcia-Porrua; Robustiano Pego-Reigosa; Trinidad Dierssen-Sotos; Javier Llorca
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

7.  Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.

Authors:  Michael S Lee; Scott D Smith; Anat Galor; Gary S Hoffman
Journal:  Arthritis Rheum       Date:  2006-10

8.  Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis?

Authors:  Wolfgang A Schmidt; Andreas Krause; Bernd Schicke; Jörn Kuchenbecker; Erika Gromnica-Ihle
Journal:  Rheumatology (Oxford)       Date:  2009-01-29       Impact factor: 7.580

9.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.

Authors:  Daniël Blockmans; Liesbet de Ceuninck; Steven Vanderschueren; Daniël Knockaert; Luc Mortelmans; Herman Bobbaers
Journal:  Arthritis Rheum       Date:  2006-02-15

10.  Giant cell arteritis and polymyalgia rheumatica in northwestern Turkey: Clinical features and epidemiological data.

Authors:  O N Pamuk; S Dönmez; B Karahan; G E Pamuk; N Cakir
Journal:  Clin Exp Rheumatol       Date:  2009 Sep-Oct       Impact factor: 4.473

View more
  15 in total

Review 1.  Giant cell arteritis: Current treatment and management.

Authors:  Cristina Ponte; Ana Filipa Rodrigues; Lorraine O'Neill; Raashid Ahmed Luqmani
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

Review 2.  Headache and temporal arteritis: when to suspect and how to manage.

Authors:  Stephanie J Nahas
Journal:  Curr Pain Headache Rep       Date:  2012-08

3.  Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.

Authors:  Matthew J Koster; Sara J Achenbach; Cynthia S Crowson; Hilal Maradit-Kremers; Eric L Matteson; Kenneth J Warrington
Journal:  J Rheumatol       Date:  2017-05-01       Impact factor: 4.666

Review 4.  Giant cell arteritis and polymyalgia rheumatica: an update.

Authors:  Miguel A González-Gay; Trinitario Pina
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

5.  Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study.

Authors:  Fatima Alnaimat; Ahmad T Mansour; Hamza Alduraidi; Soud Al-Qasem; Mohammad Hindi; Tala Rawashdeh; Eman Hassan; Sahar Almustafa; Refat Hanbali; Osama Ababneh
Journal:  Rheumatol Int       Date:  2021-10-18       Impact factor: 2.631

Review 6.  Headaches related to rheumatologic disease.

Authors:  Noa Schwartz; Hal J Mitnick; Johannes Nowatzky
Journal:  Curr Pain Headache Rep       Date:  2013-12

Review 7.  Facial nerve palsy in giant-cell arteritis: case-based review.

Authors:  Eveline Claeys; Olivier Gheysens; Wouter Meersseman; Eric Verbeken; Daniel Blockmans; Liesbet Henckaerts
Journal:  Rheumatol Int       Date:  2020-08-13       Impact factor: 2.631

8.  A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

Authors:  F David Carmona; Sarah L Mackie; Jose-Ezequiel Martín; John C Taylor; Augusto Vaglio; Stephen Eyre; Lara Bossini-Castillo; Santos Castañeda; Maria C Cid; José Hernández-Rodríguez; Sergio Prieto-González; Roser Solans; Marc Ramentol-Sintas; M Francisca González-Escribano; Lourdes Ortiz-Fernández; Inmaculada C Morado; Javier Narváez; José A Miranda-Filloy; Lorenzo Beretta; Claudio Lunardi; Marco A Cimmino; Davide Gianfreda; Daniele Santilli; Giuseppe A Ramirez; Alessandra Soriano; Francesco Muratore; Giulia Pazzola; Olga Addimanda; Cisca Wijmenga; Torsten Witte; Jan H Schirmer; Frank Moosig; Verena Schönau; Andre Franke; Øyvind Palm; Øyvind Molberg; Andreas P Diamantopoulos; Simon Carette; David Cuthbertson; Lindsy J Forbess; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Carol A McAlear; Larry Moreland; Paul A Monach; Christian Pagnoux; Philip Seo; Robert Spiera; Antoine G Sreih; Kenneth J Warrington; Steven R Ytterberg; Peter K Gregersen; Colin T Pease; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Richard Watts; Sarah Levy; Yusuf Patel; Sanjeet Kamath; Bhaskar Dasgupta; Jane Worthington; Bobby P C Koeleman; Paul I W de Bakker; Jennifer H Barrett; Carlo Salvarani; Peter A Merkel; Miguel A González-Gay; Ann W Morgan; Javier Martín
Journal:  Am J Hum Genet       Date:  2015-03-26       Impact factor: 11.025

9.  The tropics and the crime they did not commit.

Authors:  A Goorhuis; P P A M van Thiel; S Middeldorp; B L F van Eck; M P Grobusch
Journal:  Infection       Date:  2012-12-04       Impact factor: 7.455

10.  Ascending aortic aneurysm caused by Mycobacterium tuberculosis.

Authors:  Upul Pathirana; Saman Kularatne; Suneth Karunaratne; Gamini Ranasinghe; Janakie Fernando
Journal:  BMC Res Notes       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.